<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="prostate-fhir-mapping-target"/>
  <language value="en"/>
  <text>
    <status value="generated"/><div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem prostate-fhir-mapping-target</b></p><a name="prostate-fhir-mapping-target"> </a><a name="hcprostate-fhir-mapping-target"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p></div><p>This case-sensitive code system <code>https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">encounter-period<a name="prostate-fhir-mapping-target-encounter-period"> </a></td><td>Encounter.period</td></tr><tr><td style="white-space:nowrap">encounter-reason<a name="prostate-fhir-mapping-target-encounter-reason"> </a></td><td>Encounter.reasonCode</td></tr><tr><td style="white-space:nowrap">servicerequest-reason<a name="prostate-fhir-mapping-target-servicerequest-reason"> </a></td><td>ServiceRequest.reasonCode</td></tr><tr><td style="white-space:nowrap">observation-psa-serum<a name="prostate-fhir-mapping-target-observation-psa-serum"> </a></td><td>Observation: LOINC 2857-1 PSA (ObservationLt)</td></tr><tr><td style="white-space:nowrap">observation-body-height<a name="prostate-fhir-mapping-target-observation-body-height"> </a></td><td>Observation: body height (LT VitalSigns patterns)</td></tr><tr><td style="white-space:nowrap">observation-body-weight<a name="prostate-fhir-mapping-target-observation-body-weight"> </a></td><td>Observation: body weight (LT VitalSigns patterns)</td></tr><tr><td style="white-space:nowrap">observation-bmi<a name="prostate-fhir-mapping-target-observation-bmi"> </a></td><td>Observation: BMI (derived or LOINC)</td></tr><tr><td style="white-space:nowrap">observation-dre-finding<a name="prostate-fhir-mapping-target-observation-dre-finding"> </a></td><td>Observation: digital rectal examination finding (ObservationLt, exam)</td></tr><tr><td style="white-space:nowrap">observation-prior-psa<a name="prostate-fhir-mapping-target-observation-prior-psa"> </a></td><td>Observation: prior PSA value with effective time</td></tr><tr><td style="white-space:nowrap">observation-mpmri-history<a name="prostate-fhir-mapping-target-observation-mpmri-history"> </a></td><td>Observation or Procedure: prior mpMRI / PI-RADS summary</td></tr><tr><td style="white-space:nowrap">family-member-history-cancer<a name="prostate-fhir-mapping-target-family-member-history-cancer"> </a></td><td>FamilyMemberHistory (Base patterns) for oncologic family history</td></tr><tr><td style="white-space:nowrap">procedure-prior-prostate-surgery<a name="prostate-fhir-mapping-target-procedure-prior-prostate-surgery"> </a></td><td>Procedure: prior prostate surgery</td></tr><tr><td style="white-space:nowrap">procedure-prior-prostate-radiation<a name="prostate-fhir-mapping-target-procedure-prior-prostate-radiation"> </a></td><td>Procedure: prior prostate radiotherapy</td></tr><tr><td style="white-space:nowrap">medicationstatement-anticoagulant<a name="prostate-fhir-mapping-target-medicationstatement-anticoagulant"> </a></td><td>MedicationStatement: anticoagulant use</td></tr><tr><td style="white-space:nowrap">clinical-impression-or-note<a name="prostate-fhir-mapping-target-clinical-impression-or-note"> </a></td><td>Encounter / DocumentReference / ClinicalImpression for free-text programme notes</td></tr><tr><td style="white-space:nowrap">specimen-dimension-or-measurement<a name="prostate-fhir-mapping-target-specimen-dimension-or-measurement"> </a></td><td>Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)</td></tr><tr><td style="white-space:nowrap">specimen-adequacy-finding<a name="prostate-fhir-mapping-target-specimen-adequacy-finding"> </a></td><td>Observation: specimen adequacy (LT Lab)</td></tr><tr><td style="white-space:nowrap">observation-tumor-treatment-effect<a name="prostate-fhir-mapping-target-observation-tumor-treatment-effect"> </a></td><td>Observation: tumor treatment effect (TumorObservableLtLab)</td></tr><tr><td style="white-space:nowrap">condition-morphology-prostate<a name="prostate-fhir-mapping-target-condition-morphology-prostate"> </a></td><td>Condition / morphology (ProstateConditionLtLab, ICD-O)</td></tr><tr><td style="white-space:nowrap">observation-gleason-isup-prostate<a name="prostate-fhir-mapping-target-observation-gleason-isup-prostate"> </a></td><td>GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS</td></tr><tr><td style="white-space:nowrap">observation-tumor-microscopic-idc<a name="prostate-fhir-mapping-target-observation-tumor-microscopic-idc"> </a></td><td>TumorObservableLtLab / morphology for IDC</td></tr><tr><td style="white-space:nowrap">observation-tumor-microscopic-cribriform<a name="prostate-fhir-mapping-target-observation-tumor-microscopic-cribriform"> </a></td><td>TumorObservableLtLab / morphology for cribriform</td></tr><tr><td style="white-space:nowrap">observation-pattern4-percent<a name="prostate-fhir-mapping-target-observation-pattern4-percent"> </a></td><td>Observation: Pattern 4 percent band (lab tumour measurement patterns)</td></tr><tr><td style="white-space:nowrap">observation-tumor-burden-percent<a name="prostate-fhir-mapping-target-observation-tumor-burden-percent"> </a></td><td>Observation: tumour percentage in biopsy tissue</td></tr><tr><td style="white-space:nowrap">observation-periprostatic-invasion<a name="prostate-fhir-mapping-target-observation-periprostatic-invasion"> </a></td><td>Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)</td></tr><tr><td style="white-space:nowrap">observation-perineural-invasion<a name="prostate-fhir-mapping-target-observation-perineural-invasion"> </a></td><td>Observation: perineural invasion finding (LT Lab tumour findings)</td></tr><tr><td style="white-space:nowrap">observation-lymphovascular-invasion<a name="prostate-fhir-mapping-target-observation-lymphovascular-invasion"> </a></td><td>Observation: lymphovascular invasion finding (LT Lab tumour findings)</td></tr><tr><td style="white-space:nowrap">diagnosticreport-pathology-lab<a name="prostate-fhir-mapping-target-diagnosticreport-pathology-lab"> </a></td><td>PathologyReportLtLab</td></tr><tr><td style="white-space:nowrap">composition-pathology-lab<a name="prostate-fhir-mapping-target-composition-pathology-lab"> </a></td><td>PathologyCompositionLtLab</td></tr></table></div>
  </text>
  <url value="https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target"/>
  <version value="0.0.1"/>
  <name value="ProstateFhirMappingTarget"/>
  <title value="Prostate questionnaire → FHIR mapping target (illustrative)"/>
  <status value="draft"/>
  <experimental value="true"/>
  <date value="2026-03-31T08:54:25+00:00"/>
  <publisher value="Lithuanian Medical Library"/>
  <contact>
    <name value="Lithuanian Medical Library"/>
    <telecom>
      <system value="url"/>
      <value value="https://medicinosnk.lt"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="info@medicinosnk.lt"/>
    </telecom>
  </contact>
  <description value="Target **codes** for **ConceptMap** entries: each code denotes a logical FHIR mapping destination (profile or element path). Used with **prostate-adpp-questionnaire-item** and **prostate-pathology-questionnaire-item** source codes."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="LT"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="29"/>
  <concept>
    <code value="encounter-period"/>
    <display value="Encounter.period"/>
  </concept>
  <concept>
    <code value="encounter-reason"/>
    <display value="Encounter.reasonCode"/>
  </concept>
  <concept>
    <code value="servicerequest-reason"/>
    <display value="ServiceRequest.reasonCode"/>
  </concept>
  <concept>
    <code value="observation-psa-serum"/>
    <display value="Observation: LOINC 2857-1 PSA (ObservationLt)"/>
  </concept>
  <concept>
    <code value="observation-body-height"/>
    <display value="Observation: body height (LT VitalSigns patterns)"/>
  </concept>
  <concept>
    <code value="observation-body-weight"/>
    <display value="Observation: body weight (LT VitalSigns patterns)"/>
  </concept>
  <concept>
    <code value="observation-bmi"/>
    <display value="Observation: BMI (derived or LOINC)"/>
  </concept>
  <concept>
    <code value="observation-dre-finding"/>
    <display value="Observation: digital rectal examination finding (ObservationLt, exam)"/>
  </concept>
  <concept>
    <code value="observation-prior-psa"/>
    <display value="Observation: prior PSA value with effective time"/>
  </concept>
  <concept>
    <code value="observation-mpmri-history"/>
    <display value="Observation or Procedure: prior mpMRI / PI-RADS summary"/>
  </concept>
  <concept>
    <code value="family-member-history-cancer"/>
    <display value="FamilyMemberHistory (Base patterns) for oncologic family history"/>
  </concept>
  <concept>
    <code value="procedure-prior-prostate-surgery"/>
    <display value="Procedure: prior prostate surgery"/>
  </concept>
  <concept>
    <code value="procedure-prior-prostate-radiation"/>
    <display value="Procedure: prior prostate radiotherapy"/>
  </concept>
  <concept>
    <code value="medicationstatement-anticoagulant"/>
    <display value="MedicationStatement: anticoagulant use"/>
  </concept>
  <concept>
    <code value="clinical-impression-or-note"/>
    <display value="Encounter / DocumentReference / ClinicalImpression for free-text programme notes"/>
  </concept>
  <concept>
    <code value="specimen-dimension-or-measurement"/>
    <display value="Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)"/>
  </concept>
  <concept>
    <code value="specimen-adequacy-finding"/>
    <display value="Observation: specimen adequacy (LT Lab)"/>
  </concept>
  <concept>
    <code value="observation-tumor-treatment-effect"/>
    <display value="Observation: tumor treatment effect (TumorObservableLtLab)"/>
  </concept>
  <concept>
    <code value="condition-morphology-prostate"/>
    <display value="Condition / morphology (ProstateConditionLtLab, ICD-O)"/>
  </concept>
  <concept>
    <code value="observation-gleason-isup-prostate"/>
    <display value="GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS"/>
  </concept>
  <concept>
    <code value="observation-tumor-microscopic-idc"/>
    <display value="TumorObservableLtLab / morphology for IDC"/>
  </concept>
  <concept>
    <code value="observation-tumor-microscopic-cribriform"/>
    <display value="TumorObservableLtLab / morphology for cribriform"/>
  </concept>
  <concept>
    <code value="observation-pattern4-percent"/>
    <display value="Observation: Pattern 4 percent band (lab tumour measurement patterns)"/>
  </concept>
  <concept>
    <code value="observation-tumor-burden-percent"/>
    <display value="Observation: tumour percentage in biopsy tissue"/>
  </concept>
  <concept>
    <code value="observation-periprostatic-invasion"/>
    <display value="Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)"/>
  </concept>
  <concept>
    <code value="observation-perineural-invasion"/>
    <display value="Observation: perineural invasion finding (LT Lab tumour findings)"/>
  </concept>
  <concept>
    <code value="observation-lymphovascular-invasion"/>
    <display value="Observation: lymphovascular invasion finding (LT Lab tumour findings)"/>
  </concept>
  <concept>
    <code value="diagnosticreport-pathology-lab"/>
    <display value="PathologyReportLtLab"/>
  </concept>
  <concept>
    <code value="composition-pathology-lab"/>
    <display value="PathologyCompositionLtLab"/>
  </concept>
</CodeSystem>